Receptor-mediated Targeting
Receptor-Mediated Targeting is an active targeted drug delivery strategy that exploits specific interactions between ligands on a therapeutic agent or carrier and cell-surface receptors, typically overexpressed on diseased cells relative to normal tissue, to achieve selective binding, internalization, and accumulation of the drug at the intended site of action.
747
Publications
50.6K
Citations
4.8K
Authors
1.1K
Institutions
Publications per year
2017–2026
267
747
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani, Vijaya L. Dommeti, Xiaoju Wang et al. · Nature · 2014 · 952 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 747
4.8K
15
h-index
12
h-index
The University of Texas MD Anderson Cancer Center, United States
9 publications · 2.8K citations
9
h-index
8
h-index
7
h-index
1–5 of 4.8K
1.1K
Harvard University
Cambridge, United States
19 h-index
79 publications
16.2K citations

Centre National de la Recherche Scientifique
Paris, France
15 h-index
70 publications
2.5K citations
Purdue University West Lafayette
West Lafayette, United States
14 h-index
49 publications
4.8K citations

University of Alabama at Birmingham
Birmingham, United States
14 h-index
61 publications
3.3K citations
National Cancer Institute
Bethesda, United States
12 h-index
75 publications
37.9K citations

Howard Hughes Medical Institute
Chevy Chase, United States
12 h-index
43 publications
5.5K citations
Center for Cancer Research
Bethesda, United States
11 h-index
43 publications
10.7K citations
Fudan University
Shanghai, China
11 h-index
64 publications
3.7K citations
1–8 of 1.1K
26 publications · 2.5K citations
21
h-index
22 publications · 2K citations
20
h-index
Repository · 24 publications · 1.5K citations
19
h-index
PNAS · 17 publications · 1.4K citations
16
h-index
15 publications · 657 citations
15
h-index
1–5